Profound Medical Corp. — Form 8-K
Filed November 3, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 52/100
What the filing says
Profound Medical entered a supply and distribution agreement effective October 23, 2026 with Cook Medical Holdings LLC to distribute TULSA-PRO systems in the United States through Cook's iMRI Division and Copernicus program. Cook will purchase TULSA-PRO systems at a predetermined transfer price (specific price redacted) for resale, while Profound retains direct recurring revenue from disposables and service contracts. The agreement includes minimum sales thresholds (redacted %) tied to Cook iMRI Equipment units, with a 5-year initial term beginning upon FDA clearance, auto-renewing annually unless terminated with 180-day notice.
Why this rating
Material distribution channel expansion with major medical device OEM; Cook's scale and existing hospital relationships should drive TULSA-PRO placements. However, specific transfer pricing, volume commitments, and minimum thresholds redacted limit quantifiable upside assessment. Positive for recurring revenue base but introduces channel conflict with direct sales.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.